首页> 外文期刊>Heart >Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period
【24h】

Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period

机译:植入式心脏复律除颤器治疗的年龄依赖性疗效:在11年期间的450例患者中的观察

获取原文
获取原文并翻译 | 示例
       

摘要

Conclusions-Elderly patients benefit from ICD treatment, and survive for a considerable time after the first treat- ment. Therefore, elderly patients should be considered candidates for ICD implan- tation if life threatening ventricular tachy- arrhythmias are present. Objective-To determine whether im- Plantable cardioverter-defibrillator (ICD) Treatment is beneficial in elderly patients With life threatening ventricular tachya- Rhythmias. Design-Since January 1984, ICDs were Implanted in 450 patients to evaluate sur- Gical risk, complications and mean sur- Vival in relation to patient age; 81 patients (18/100) were ≤ 50 years at the time of ICD implant, 254 patients (56/100) were between 51 and 64 years, and the remaining 115 (26/100) were ≥ 65 years.
机译:结论老年患者受益于ICD治疗,并且在首次治疗后可以存活相当长的时间。因此,如果存在危及生命的室性心律失常,应考虑将老年患者考虑为ICD植入术的候选人。目的-确定植入式心脏复律除颤器(ICD)治疗对危及生命的室速性心律失常的老年患者是否有益。设计-自1984年1月以来,在450例患者中植入了ICD,以评估与患者年龄相关的手术风险,并发症和平均生存率。在植入ICD时,有81例(18/100)≤50岁,有254例(56/100)在51至64岁之间,其余115例(26/100)≥65岁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号